首页 > 最新文献

Scandinavian Journal of Infectious Diseases最新文献

英文 中文
Tuberculosis among HIV-infected patients in Stockholm, Sweden, 1987-2010: treatment outcomes and adverse reactions. 1987-2010年瑞典斯德哥尔摩艾滋病毒感染患者的结核病:治疗结果和不良反应。
Pub Date : 2014-05-01 Epub Date: 2014-02-11 DOI: 10.3109/00365548.2013.878033
Carolina Wannheden, Maria Norrby, Ingela Berggren, Katarina Westling

Background: The treatment of patients co-infected with human immunodeficiency virus (HIV) and tuberculosis (TB) is challenging. The aim of this study was to compare socio-demographic and clinical characteristics among HIV-infected patients before and after the introduction of combined antiretroviral therapy (cART) in a Swedish cohort, and to identify factors associated with anti-TB treatment success as well as adverse reactions.

Methods: This was a retrospective observational study of HIV/TB co-infected patients in Stockholm County from 1987 to 2010. The study population was stratified into an early and a late cohort (before and after the introduction of cART in 1996). Data were analyzed using descriptive statistics and multiple logistic regression analysis.

Results: The study population comprised 127 patients; the majority were foreign-born (87%). The proportion of female patients more than doubled from the early to the late cohort, and anti-TB treatment success increased from 65% to 91%. The median duration of successful treatment was 8 months in both cohorts. Predictors of treatment success in the late cohort were cART (odds ratio (OR) 13.3, 95% confidence interval (CI) 1.5-114.8) and a CD4 cell count at TB diagnosis > 200 cells/μl (OR 17.2, 95% CI 1.2-236.6). Severe adverse reactions in the late cohort occurred in 23% and were associated with the initiation of cART after TB diagnosis (OR 13.3, 95% CI 1.6-112.4).

Conclusion: The introduction of cART was favourable for the treatment outcome of HIV-infected patients with concomitant TB. However, adverse reactions increased in patients who initiated cART during anti-TB treatment and these patients require careful attention.

背景:人类免疫缺陷病毒(HIV)和结核病(TB)合并感染患者的治疗具有挑战性。本研究的目的是比较瑞典队列中引入联合抗逆转录病毒治疗(cART)前后hiv感染患者的社会人口统计学和临床特征,并确定与抗结核治疗成功以及不良反应相关的因素。方法:对1987 - 2010年斯德哥尔摩县HIV/TB合并感染患者进行回顾性观察研究。研究人群被分为早期和晚期队列(1996年引入cART之前和之后)。数据分析采用描述性统计和多元逻辑回归分析。结果:研究人群包括127例患者;大多数是外国出生的(87%)。女性患者的比例从早期到晚期增加了一倍多,抗结核治疗成功率从65%增加到91%。在两个队列中,成功治疗的中位持续时间为8个月。晚期队列治疗成功的预测因子为cART(比值比(OR) 13.3, 95%可信区间(CI) 1.5-114.8)和TB诊断时CD4细胞计数> 200细胞/μl (OR 17.2, 95% CI 1.2-236.6)。晚期队列中发生严重不良反应的比例为23%,并且与结核诊断后开始cART相关(OR 13.3, 95% CI 1.6-112.4)。结论:cART的引入有利于hiv感染合并结核病患者的治疗效果。然而,在抗结核治疗期间开始cART治疗的患者的不良反应增加,这些患者需要仔细注意。
{"title":"Tuberculosis among HIV-infected patients in Stockholm, Sweden, 1987-2010: treatment outcomes and adverse reactions.","authors":"Carolina Wannheden,&nbsp;Maria Norrby,&nbsp;Ingela Berggren,&nbsp;Katarina Westling","doi":"10.3109/00365548.2013.878033","DOIUrl":"https://doi.org/10.3109/00365548.2013.878033","url":null,"abstract":"<p><strong>Background: </strong>The treatment of patients co-infected with human immunodeficiency virus (HIV) and tuberculosis (TB) is challenging. The aim of this study was to compare socio-demographic and clinical characteristics among HIV-infected patients before and after the introduction of combined antiretroviral therapy (cART) in a Swedish cohort, and to identify factors associated with anti-TB treatment success as well as adverse reactions.</p><p><strong>Methods: </strong>This was a retrospective observational study of HIV/TB co-infected patients in Stockholm County from 1987 to 2010. The study population was stratified into an early and a late cohort (before and after the introduction of cART in 1996). Data were analyzed using descriptive statistics and multiple logistic regression analysis.</p><p><strong>Results: </strong>The study population comprised 127 patients; the majority were foreign-born (87%). The proportion of female patients more than doubled from the early to the late cohort, and anti-TB treatment success increased from 65% to 91%. The median duration of successful treatment was 8 months in both cohorts. Predictors of treatment success in the late cohort were cART (odds ratio (OR) 13.3, 95% confidence interval (CI) 1.5-114.8) and a CD4 cell count at TB diagnosis > 200 cells/μl (OR 17.2, 95% CI 1.2-236.6). Severe adverse reactions in the late cohort occurred in 23% and were associated with the initiation of cART after TB diagnosis (OR 13.3, 95% CI 1.6-112.4).</p><p><strong>Conclusion: </strong>The introduction of cART was favourable for the treatment outcome of HIV-infected patients with concomitant TB. However, adverse reactions increased in patients who initiated cART during anti-TB treatment and these patients require careful attention.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2013.878033","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32103043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Are procalcitonin or other infection markers useful in the detection of group A streptococcal acute tonsillitis? 降钙素原或其他感染标志物在A组链球菌急性扁桃体炎检测中有用吗?
Pub Date : 2014-05-01 Epub Date: 2014-03-10 DOI: 10.3109/00365548.2014.885656
Ann Marlene Gram Christensen, Marianne Kragh Thomsen, Therese Ovesen, Tejs Ehlers Klug

Background: The Centor criteria and the streptococcal rapid antigen detection test (RADT) are commonly used to differentiate sore throat patients with group A streptococci (GAS) from patients with other pathogens. We aimed to investigate if procalcitonin (PCT), C-reactive protein (CRP), white blood cell count (WBC), and absolute neutrophil count (ANC) could increase the diagnostic accuracy when added to the Centor score and RADT, or be used instead of the RADT, in the differential diagnosis.

Methods: A 6-month prospective study was carried out in a Danish general practice with 8 physicians. One hundred acute tonsillitis patients aged 15 to 40 y were included.

Results: The prevalence of GAS was 26%. The sensitivity (90%) and specificity (97%) of the RADT were high. Mean values of CRP, WBC, and ANC were significantly higher in patients with GAS compared to non-GAS patients (p < 0.001). However, the sensitivities (66-90%) and specificities (45-75%) were low. No difference in PCT levels was found (p = 0.334). CRP was the most reliable infection marker (sensitivity 90% and specificity 45%) for GAS aetiology.

Conclusions: The sensitivity, specificity, and area under the curve of the RADT were higher than those of the 4 measured infection markers in the differentiation between GAS and non-GAS acute tonsillitis patients. The infection markers did not increase the diagnostic accuracy when added to the Centor score and RADT. When RADT is not available, measurement of CRP or ANC may increase the diagnostic accuracy in the detection of GAS-positive patients.

背景:常用Centor标准和链球菌快速抗原检测试验(RADT)来区分A组链球菌(GAS)咽喉痛患者和其他病原体患者。我们的目的是研究降钙素原(PCT)、c反应蛋白(CRP)、白细胞计数(WBC)和绝对中性粒细胞计数(ANC)是否可以增加Centor评分和RADT的诊断准确性,或者代替RADT用于鉴别诊断。方法:一项为期6个月的前瞻性研究在丹麦全科医生8进行。研究对象为100例15 ~ 40岁的急性扁桃体炎患者。结果:GAS的患病率为26%。RADT具有较高的灵敏度(90%)和特异性(97%)。与非GAS患者相比,GAS患者CRP、WBC和ANC的平均值显著升高(p < 0.001)。然而,敏感性(66-90%)和特异性(45-75%)较低。PCT水平差异无统计学意义(p = 0.334)。CRP是GAS病因最可靠的感染标志物(敏感性90%,特异性45%)。结论:RADT在鉴别急性扁桃体炎与非急性扁桃体炎的敏感性、特异性和曲线下面积均高于4种检测感染标志物。当将感染标记物与Centor评分和RADT加在一起时,并没有增加诊断的准确性。当不能使用RADT时,测量CRP或ANC可提高检测gas阳性患者的诊断准确性。
{"title":"Are procalcitonin or other infection markers useful in the detection of group A streptococcal acute tonsillitis?","authors":"Ann Marlene Gram Christensen,&nbsp;Marianne Kragh Thomsen,&nbsp;Therese Ovesen,&nbsp;Tejs Ehlers Klug","doi":"10.3109/00365548.2014.885656","DOIUrl":"https://doi.org/10.3109/00365548.2014.885656","url":null,"abstract":"<p><strong>Background: </strong>The Centor criteria and the streptococcal rapid antigen detection test (RADT) are commonly used to differentiate sore throat patients with group A streptococci (GAS) from patients with other pathogens. We aimed to investigate if procalcitonin (PCT), C-reactive protein (CRP), white blood cell count (WBC), and absolute neutrophil count (ANC) could increase the diagnostic accuracy when added to the Centor score and RADT, or be used instead of the RADT, in the differential diagnosis.</p><p><strong>Methods: </strong>A 6-month prospective study was carried out in a Danish general practice with 8 physicians. One hundred acute tonsillitis patients aged 15 to 40 y were included.</p><p><strong>Results: </strong>The prevalence of GAS was 26%. The sensitivity (90%) and specificity (97%) of the RADT were high. Mean values of CRP, WBC, and ANC were significantly higher in patients with GAS compared to non-GAS patients (p < 0.001). However, the sensitivities (66-90%) and specificities (45-75%) were low. No difference in PCT levels was found (p = 0.334). CRP was the most reliable infection marker (sensitivity 90% and specificity 45%) for GAS aetiology.</p><p><strong>Conclusions: </strong>The sensitivity, specificity, and area under the curve of the RADT were higher than those of the 4 measured infection markers in the differentiation between GAS and non-GAS acute tonsillitis patients. The infection markers did not increase the diagnostic accuracy when added to the Centor score and RADT. When RADT is not available, measurement of CRP or ANC may increase the diagnostic accuracy in the detection of GAS-positive patients.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2014.885656","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40291128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
A morphology-based method for the diagnosis of red blood cells parasitized by Plasmodium malariae and Plasmodium ovale. 一种基于形态学的疟疾疟原虫和卵形疟原虫寄生红细胞诊断方法。
Pub Date : 2014-05-01 Epub Date: 2014-02-25 DOI: 10.3109/00365548.2014.880186
Alireza Karimi, Mahdi Navidbakhsh, Afsaneh Motevalli Haghi, Shahab Faghihi

Background: The morphology of red blood cells (RBCs) is altered significantly during the maturation stages of malaria parasites, which include ring, trophozoite, and schizont. There is dissimilarity in terms of the morphological characteristics of parasitized RBCs infected by the 4 species of Plasmodium, including falciparum, vivax, malariae, and ovale. This makes the process of diagnosis very difficult, which may lead to a wrong treatment method and substantial damage to the health of the patient. An innovative technique in introduced that accurately defines the shape of parasitized RBCs at each stage of infection as a potential method of diagnosis.

Methods: Giemsa-stained thin blood films were prepared using blood samples collected from healthy donors as well as patients infected with P. malariae and P. ovale. The diameter and thickness of healthy and infected RBCs at each stage of infection were measured from their optical images using Olysia and Scanning Probe Image Processor (SPIP) software, respectively. A shape equation was fitted based on the morphological characteristics of RBCs, and their relative 2-dimensional shapes were plotted using Wolfram Mathematica.

Results: At the ring stage, the thicknesses of RBCs parasitized by P. malariae (Pm-RBCs) and P. ovale (Po-RBCs) increased by 42% and 51%, respectively. Both Pm-RBCs and Po-RBCs remained nearly biconcave throughout parasite development even though their volumes increased.

Conclusions: It is proposed that the morphology-based characterization technique introduced here could be used to intensify the accuracy of the Giemsa staining diagnosis method for the detection of the Plasmodium genus and infection stage. Based on the significant morphological alterations induced by different Plasmodium species, the results may also find practical use for faster prediction and treatment of human malaria.

背景:在疟疾寄生虫的成熟阶段,红细胞(rbc)的形态发生了显著的改变,包括环体、滋养体和分裂体。恶性疟原虫、间日疟原虫、疟疾疟原虫、卵圆疟原虫等4种疟原虫感染后被寄生红细胞的形态特征存在差异。这使得诊断过程非常困难,这可能导致错误的治疗方法,并对患者的健康造成实质性损害。介绍了一种创新的技术,可以准确地确定感染每个阶段被寄生红细胞的形状,作为一种潜在的诊断方法。方法:采集健康献血者、疟疾疟原虫和卵形疟原虫感染患者的血液,制备吉姆萨染色血膜。分别用Olysia和SPIP扫描探针图像处理器(Scanning Probe Image Processor, SPIP)软件测量健康红细胞和感染红细胞在感染各阶段的直径和厚度。根据红细胞的形态特征拟合形状方程,利用Wolfram Mathematica软件绘制红细胞的相对二维形状。结果:在环期,疟原虫寄生红细胞(pm - rbc)和卵形疟原虫(po - rbc)的厚度分别增加42%和51%。pm -红细胞和po -红细胞在整个寄生虫发育过程中几乎保持双凹形,尽管它们的体积增加了。结论:基于形态学的鉴定技术可提高吉姆萨染色诊断方法检测疟原虫属和感染阶段的准确性。基于不同疟原虫种类引起的显著形态改变,该结果也可能为更快地预测和治疗人类疟疾找到实际用途。
{"title":"A morphology-based method for the diagnosis of red blood cells parasitized by Plasmodium malariae and Plasmodium ovale.","authors":"Alireza Karimi,&nbsp;Mahdi Navidbakhsh,&nbsp;Afsaneh Motevalli Haghi,&nbsp;Shahab Faghihi","doi":"10.3109/00365548.2014.880186","DOIUrl":"https://doi.org/10.3109/00365548.2014.880186","url":null,"abstract":"<p><strong>Background: </strong>The morphology of red blood cells (RBCs) is altered significantly during the maturation stages of malaria parasites, which include ring, trophozoite, and schizont. There is dissimilarity in terms of the morphological characteristics of parasitized RBCs infected by the 4 species of Plasmodium, including falciparum, vivax, malariae, and ovale. This makes the process of diagnosis very difficult, which may lead to a wrong treatment method and substantial damage to the health of the patient. An innovative technique in introduced that accurately defines the shape of parasitized RBCs at each stage of infection as a potential method of diagnosis.</p><p><strong>Methods: </strong>Giemsa-stained thin blood films were prepared using blood samples collected from healthy donors as well as patients infected with P. malariae and P. ovale. The diameter and thickness of healthy and infected RBCs at each stage of infection were measured from their optical images using Olysia and Scanning Probe Image Processor (SPIP) software, respectively. A shape equation was fitted based on the morphological characteristics of RBCs, and their relative 2-dimensional shapes were plotted using Wolfram Mathematica.</p><p><strong>Results: </strong>At the ring stage, the thicknesses of RBCs parasitized by P. malariae (Pm-RBCs) and P. ovale (Po-RBCs) increased by 42% and 51%, respectively. Both Pm-RBCs and Po-RBCs remained nearly biconcave throughout parasite development even though their volumes increased.</p><p><strong>Conclusions: </strong>It is proposed that the morphology-based characterization technique introduced here could be used to intensify the accuracy of the Giemsa staining diagnosis method for the detection of the Plasmodium genus and infection stage. Based on the significant morphological alterations induced by different Plasmodium species, the results may also find practical use for faster prediction and treatment of human malaria.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2014.880186","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32152443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Chronic hepatitis C in Swedish subjects receiving opiate substitution therapy--factors associated with advanced fibrosis. 接受阿片类药物替代治疗的瑞典慢性丙型肝炎患者——与晚期纤维化相关的因素
Pub Date : 2014-05-01 Epub Date: 2014-02-20 DOI: 10.3109/00365548.2013.879994
Anna Jerkeman, Johan Westin, Martin Lagging, Gunnar Norkrans, Christer Lidman, Jan Frimand, Christian Simonsberg, Johan Kakko, Anders Widell, Per Björkman

Background: Opiate substitution therapy (OST) reduces the risk of death from directly drug-related causes in heroin users, allowing other chronic health problems to emerge. People who inject drugs (PWID) are exposed to hepatitis C virus (HCV), with an associated risk of chronic liver disease. We investigated HCV prevalence and liver-related morbidity in a cohort of OST recipients, and analyzed factors associated with significant hepatic fibrosis.

Methods: All patients registered on 1 April 2008 in 4 clinics providing OST in the 3 largest cities in Sweden were eligible for inclusion. HCV viremic subjects were evaluated for fibrosis stage by liver biopsy, transient elastometry (TE), and/or a biochemical fibrosis index (Göteborg University Cirrhosis Index; GUCI). Factors associated with severity of fibrosis were determined by logistic regression analysis.

Results: Out of 524 eligible patients, 277 consented to enrolment. Two hundred and thirty-six subjects (88%) were anti-HCV-positive, and 162 of these were viremic (69%). Significant liver fibrosis (defined as Ishak stages F3-F6, TE value ≥ 8.85 kPa, or GUCI > 0.33) was found in 69 out of 103 (67%) tested viremic patients, and was associated with alcohol intake (p = 0.03), higher body mass index (BMI; p = 0.04), and the presence of anti-HBc antibodies (indicating exposure to hepatitis B virus (HBV); p = 0.02).

Conclusions: Significant liver fibrosis was detected in two-thirds of HCV viremic OST recipients in this cohort, and was associated with alcohol use, high BMI, and exposure to HBV. These findings indicate that the management of HCV and associated risk factors should be emphasized in Swedish OST programs.

背景:阿片替代疗法(OST)降低了海洛因使用者直接因药物相关原因死亡的风险,从而导致其他慢性健康问题的出现。注射吸毒者(PWID)暴露于丙型肝炎病毒(HCV),具有慢性肝病的相关风险。我们调查了一组OST接受者的HCV患病率和肝脏相关发病率,并分析了显著肝纤维化的相关因素。方法:2008年4月1日在瑞典3个最大城市提供OST的4家诊所登记的所有患者均符合纳入条件。HCV病毒血症患者通过肝活检、瞬时弹性测量(TE)和/或生化纤维化指数(Göteborg大学肝硬化指数;鼓词)。通过logistic回归分析确定与纤维化严重程度相关的因素。结果:在524例符合条件的患者中,277例同意入组。236例(88%)抗hcv阳性,其中162例(69%)病毒血症。103例(67%)病毒血症患者中有69例(定义为Ishak分期F3-F6, TE值≥8.85 kPa,或GUCI > 0.33)存在显著肝纤维化,且与酒精摄入(p = 0.03)、较高的体重指数(BMI;p = 0.04),以及抗hbc抗体的存在(表明暴露于乙型肝炎病毒(HBV);P = 0.02)。结论:在该队列中,三分之二的HCV病毒血症OST受者检测到明显的肝纤维化,并与饮酒、高BMI和HBV暴露有关。这些发现表明,在瑞典的OST项目中,HCV和相关危险因素的管理应得到重视。
{"title":"Chronic hepatitis C in Swedish subjects receiving opiate substitution therapy--factors associated with advanced fibrosis.","authors":"Anna Jerkeman,&nbsp;Johan Westin,&nbsp;Martin Lagging,&nbsp;Gunnar Norkrans,&nbsp;Christer Lidman,&nbsp;Jan Frimand,&nbsp;Christian Simonsberg,&nbsp;Johan Kakko,&nbsp;Anders Widell,&nbsp;Per Björkman","doi":"10.3109/00365548.2013.879994","DOIUrl":"https://doi.org/10.3109/00365548.2013.879994","url":null,"abstract":"<p><strong>Background: </strong>Opiate substitution therapy (OST) reduces the risk of death from directly drug-related causes in heroin users, allowing other chronic health problems to emerge. People who inject drugs (PWID) are exposed to hepatitis C virus (HCV), with an associated risk of chronic liver disease. We investigated HCV prevalence and liver-related morbidity in a cohort of OST recipients, and analyzed factors associated with significant hepatic fibrosis.</p><p><strong>Methods: </strong>All patients registered on 1 April 2008 in 4 clinics providing OST in the 3 largest cities in Sweden were eligible for inclusion. HCV viremic subjects were evaluated for fibrosis stage by liver biopsy, transient elastometry (TE), and/or a biochemical fibrosis index (Göteborg University Cirrhosis Index; GUCI). Factors associated with severity of fibrosis were determined by logistic regression analysis.</p><p><strong>Results: </strong>Out of 524 eligible patients, 277 consented to enrolment. Two hundred and thirty-six subjects (88%) were anti-HCV-positive, and 162 of these were viremic (69%). Significant liver fibrosis (defined as Ishak stages F3-F6, TE value ≥ 8.85 kPa, or GUCI > 0.33) was found in 69 out of 103 (67%) tested viremic patients, and was associated with alcohol intake (p = 0.03), higher body mass index (BMI; p = 0.04), and the presence of anti-HBc antibodies (indicating exposure to hepatitis B virus (HBV); p = 0.02).</p><p><strong>Conclusions: </strong>Significant liver fibrosis was detected in two-thirds of HCV viremic OST recipients in this cohort, and was associated with alcohol use, high BMI, and exposure to HBV. These findings indicate that the management of HCV and associated risk factors should be emphasized in Swedish OST programs.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2013.879994","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32138578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Changes over time in the Chlamydia trachomatis serotype distribution in Finnish women. 芬兰妇女沙眼衣原体血清型分布随时间的变化。
Pub Date : 2014-05-01 Epub Date: 2014-02-11 DOI: 10.3109/00365548.2013.878031
Erika Wikström, Heljä-Marja Surcel, Marko Merikukka, Hanna Ohman, Proscovia B Namujju, Kaisa Tasanen, Aila Tiitinen, Jorma Paavonen, Matti Lehtinen

The distribution of Chlamydia trachomatis serotypes in the sexually active population may change over time. Serum from C. trachomatis seropositive women representing the 1980s, 1990s, and 2000s were available from a stratified random sample (11,067) of the Finnish Maternity Cohort for microimmunofluorescence-based classification. The C. trachomatis serotype distributions in the 1980s and 2000s were comparable, with serotypes G, E, and J being the most prevalent. In the 1990s the numbers of women seropositive for ≥ 2 serotypes peaked, and serotypes G/J were replaced by serotypes E/D. The temporary C. trachomatis serotype replacement parallels changes in the sexually active population in the 1990s in Finland.

沙眼衣原体血清型在性活跃人群中的分布可能随时间而改变。从芬兰产妇队列的分层随机样本(11067人)中获得1980年代、1990年代和2000年代沙眼衣原体血清阳性妇女的血清,用于微免疫荧光分类。1980年代和2000年代沙眼衣原体血清型分布具有可比性,以G、E、J血清型最为流行。20世纪90年代,妇女血清≥2种血清型阳性人数达到高峰,G/J血清型被E/D血清型所取代。临时的沙眼衣原体血清型替换与20世纪90年代芬兰性活跃人群的变化相似。
{"title":"Changes over time in the Chlamydia trachomatis serotype distribution in Finnish women.","authors":"Erika Wikström,&nbsp;Heljä-Marja Surcel,&nbsp;Marko Merikukka,&nbsp;Hanna Ohman,&nbsp;Proscovia B Namujju,&nbsp;Kaisa Tasanen,&nbsp;Aila Tiitinen,&nbsp;Jorma Paavonen,&nbsp;Matti Lehtinen","doi":"10.3109/00365548.2013.878031","DOIUrl":"https://doi.org/10.3109/00365548.2013.878031","url":null,"abstract":"<p><p>The distribution of Chlamydia trachomatis serotypes in the sexually active population may change over time. Serum from C. trachomatis seropositive women representing the 1980s, 1990s, and 2000s were available from a stratified random sample (11,067) of the Finnish Maternity Cohort for microimmunofluorescence-based classification. The C. trachomatis serotype distributions in the 1980s and 2000s were comparable, with serotypes G, E, and J being the most prevalent. In the 1990s the numbers of women seropositive for ≥ 2 serotypes peaked, and serotypes G/J were replaced by serotypes E/D. The temporary C. trachomatis serotype replacement parallels changes in the sexually active population in the 1990s in Finland.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2013.878031","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32103044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls. 糖尿病与坦桑尼亚结核病患者和非结核病对照者较低的结核病抗原特异性干扰素γ释放有关。
Pub Date : 2014-05-01 Epub Date: 2014-03-12 DOI: 10.3109/00365548.2014.885657
Daniel Faurholt-Jepsen, Martine Grosos Aabye, Andreas Vestergaard Jensen, Nyagosya Range, George Praygod, Kidola Jeremiah, John Changalucha, Maria Faurholt-Jepsen, Lotte Jensen, Signe Marie Jensen, Henrik Krarup, Pernille Ravn, Henrik Friis, Ase Bengård Andersen

Background: Diabetes is increasingly common in TB endemic regions and plays a role as a possible risk factor for increased progression from latent TB infection (LTBI) to active TB disease. Although the pathophysiological mechanisms are not fully understood, the immune system is weakened in diabetes patients and therefore the validity of interferon gamma release assays (IGRA) may be compromised. The aim of the present study was to assess the association between diabetes and Mycobacterium tuberculosis (Mtb) antigen-specific interferon gamma (IFN-γ) release in a TB endemic area among culture-confirmed TB patients and non-TB controls.

Methods: Culture-confirmed pulmonary TB patients (n = 187) and healthy non-TB neighbourhood controls (n = 190) from Mwanza, Tanzania were tested for the presence of circulating T cells recognizing Mtb antigens using an IGRA. The diabetes status of all participants was assessed using a standard oral glucose tolerance test. The impact of diabetes on the performance of the IGRA was estimated using robust linear and logistic regression.

Results: Compared to normal glucose tolerance, diabetes was associated with reduced levels of Mtb-specific IFN-γ. Increasing levels of fasting blood glucose (B - 0.3, 95% confidence interval - 0.6 to - 0.03, p = 0.033) was negatively associated with IFN-γ. Although TB patients had higher specific and lower unspecific mitogen IFN-γ responses compared to non-TB controls, the association between diabetes and IFN-γ did not depend on TB status.

Conclusion: Diabetes is associated with lower levels of Mtb antigen-specific IFN-γ, and the validity of IFN- γ tests for LTBI may be questionable in individuals with diabetes.

背景:糖尿病在结核病流行地区越来越普遍,并可能成为潜伏性结核感染(LTBI)向活动性结核病发展的一个危险因素。虽然病理生理机制尚不完全清楚,但糖尿病患者的免疫系统减弱,因此干扰素γ释放试验(IGRA)的有效性可能受到损害。本研究的目的是评估糖尿病与结核分枝杆菌(Mtb)抗原特异性干扰素γ (IFN-γ)在结核流行区培养确诊结核患者和非结核对照者中的释放之间的关系。方法:使用IGRA检测来自坦桑尼亚Mwanza的培养确诊肺结核患者(187例)和健康的非结核病社区对照(190例)是否存在识别结核分枝杆菌抗原的循环T细胞。使用标准的口服葡萄糖耐量试验评估所有参与者的糖尿病状况。糖尿病对IGRA性能的影响使用稳健线性和逻辑回归进行估计。结果:与正常糖耐量相比,糖尿病与mtb特异性IFN-γ水平降低相关。空腹血糖水平升高(B - 0.3, 95%可信区间为- 0.6至- 0.03,p = 0.033)与IFN-γ呈负相关。尽管与非结核病对照相比,结核病患者具有更高的特异性和更低的非特异性丝裂原IFN-γ反应,但糖尿病和IFN-γ之间的关联并不取决于结核病状况。结论:糖尿病与Mtb抗原特异性IFN-γ水平降低有关,而IFN-γ检测LTBI在糖尿病患者中的有效性可能值得怀疑。
{"title":"Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls.","authors":"Daniel Faurholt-Jepsen,&nbsp;Martine Grosos Aabye,&nbsp;Andreas Vestergaard Jensen,&nbsp;Nyagosya Range,&nbsp;George Praygod,&nbsp;Kidola Jeremiah,&nbsp;John Changalucha,&nbsp;Maria Faurholt-Jepsen,&nbsp;Lotte Jensen,&nbsp;Signe Marie Jensen,&nbsp;Henrik Krarup,&nbsp;Pernille Ravn,&nbsp;Henrik Friis,&nbsp;Ase Bengård Andersen","doi":"10.3109/00365548.2014.885657","DOIUrl":"https://doi.org/10.3109/00365548.2014.885657","url":null,"abstract":"<p><strong>Background: </strong>Diabetes is increasingly common in TB endemic regions and plays a role as a possible risk factor for increased progression from latent TB infection (LTBI) to active TB disease. Although the pathophysiological mechanisms are not fully understood, the immune system is weakened in diabetes patients and therefore the validity of interferon gamma release assays (IGRA) may be compromised. The aim of the present study was to assess the association between diabetes and Mycobacterium tuberculosis (Mtb) antigen-specific interferon gamma (IFN-γ) release in a TB endemic area among culture-confirmed TB patients and non-TB controls.</p><p><strong>Methods: </strong>Culture-confirmed pulmonary TB patients (n = 187) and healthy non-TB neighbourhood controls (n = 190) from Mwanza, Tanzania were tested for the presence of circulating T cells recognizing Mtb antigens using an IGRA. The diabetes status of all participants was assessed using a standard oral glucose tolerance test. The impact of diabetes on the performance of the IGRA was estimated using robust linear and logistic regression.</p><p><strong>Results: </strong>Compared to normal glucose tolerance, diabetes was associated with reduced levels of Mtb-specific IFN-γ. Increasing levels of fasting blood glucose (B - 0.3, 95% confidence interval - 0.6 to - 0.03, p = 0.033) was negatively associated with IFN-γ. Although TB patients had higher specific and lower unspecific mitogen IFN-γ responses compared to non-TB controls, the association between diabetes and IFN-γ did not depend on TB status.</p><p><strong>Conclusion: </strong>Diabetes is associated with lower levels of Mtb antigen-specific IFN-γ, and the validity of IFN- γ tests for LTBI may be questionable in individuals with diabetes.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2014.885657","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40302511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 41
Distribution and perinatal transmission of bacterial vaginal infections in pregnant women without vaginal symptoms. 无阴道症状孕妇阴道细菌性感染的分布及围生期传播。
Pub Date : 2014-05-01 Epub Date: 2014-02-20 DOI: 10.3109/00365548.2014.880183
Ho-Suap Hahn, Ki-Heon Lee, Yu-Jin Koo, Soon-Gyu Kim, Jee Eun Rhee, Moon Young Kim, Soo-Jin Hwang, Jae Ho Lee, In-Ho Lee, Kyung-Taek Lim, Jae-Uk Shim, Tae-Jin Kim

Background: We evaluated the distribution and vertical transmission of bacterial vaginal infections in asymptomatic pregnant women.

Methods: We performed multiplex PCR on secretions collected on cervical swabs from pregnant women at over 36 weeks of gestation and on oral secretions collected from their neonates immediately after delivery. We detected sexually transmitted infections (STIs) with the following 6 species: Trichomonas vaginalis, Mycoplasma hominis, Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, and Ureaplasma urealyticum.

Results: Infectious agents were detected in 64 of 455 pregnant women (14.1%) and in 11 neonates (2.4%). The rate of vertical transmission was 17.2% and all the infectious agents detected in neonates were concordant with those found in their mothers. U. urealyticum was the most frequently detected in the maternal genitalia, followed by M. hominis. Women who were in labor for a longer period of time had a higher risk of vertically transmitting STI agents to their neonates.

Conclusions: Vertical transmission of bacterial STIs from mothers to their infants is possible at delivery and influenced by the duration of labor. STIs should be diagnosed in pregnant women to prevent vertical transmission from the mother to the infant at the time of delivery.

背景:我们评估无症状孕妇阴道细菌性感染的分布和垂直传播。方法:对妊娠36周以上孕妇的宫颈拭子分泌物和分娩后立即收集的新生儿口腔分泌物进行多重PCR。检测出6种性传播感染:阴道毛滴虫、人支原体、生殖支原体、沙眼衣原体、淋病奈瑟菌、解脲原体。结果:455例孕妇中检出感染源64例(14.1%),新生儿检出感染源11例(2.4%)。垂直传播率为17.2%,新生儿感染病原与母亲感染病原基本一致。母系生殖器检出最多的是解脲脲菌,其次是人支原体。分娩时间较长的妇女将性传播感染媒介垂直传播给新生儿的风险更高。结论:细菌性传播感染可能在分娩时由母亲垂直传播给婴儿,并受分娩时间的影响。应在孕妇中诊断性传播感染,以防止在分娩时从母亲向婴儿垂直传播。
{"title":"Distribution and perinatal transmission of bacterial vaginal infections in pregnant women without vaginal symptoms.","authors":"Ho-Suap Hahn,&nbsp;Ki-Heon Lee,&nbsp;Yu-Jin Koo,&nbsp;Soon-Gyu Kim,&nbsp;Jee Eun Rhee,&nbsp;Moon Young Kim,&nbsp;Soo-Jin Hwang,&nbsp;Jae Ho Lee,&nbsp;In-Ho Lee,&nbsp;Kyung-Taek Lim,&nbsp;Jae-Uk Shim,&nbsp;Tae-Jin Kim","doi":"10.3109/00365548.2014.880183","DOIUrl":"https://doi.org/10.3109/00365548.2014.880183","url":null,"abstract":"<p><strong>Background: </strong>We evaluated the distribution and vertical transmission of bacterial vaginal infections in asymptomatic pregnant women.</p><p><strong>Methods: </strong>We performed multiplex PCR on secretions collected on cervical swabs from pregnant women at over 36 weeks of gestation and on oral secretions collected from their neonates immediately after delivery. We detected sexually transmitted infections (STIs) with the following 6 species: Trichomonas vaginalis, Mycoplasma hominis, Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, and Ureaplasma urealyticum.</p><p><strong>Results: </strong>Infectious agents were detected in 64 of 455 pregnant women (14.1%) and in 11 neonates (2.4%). The rate of vertical transmission was 17.2% and all the infectious agents detected in neonates were concordant with those found in their mothers. U. urealyticum was the most frequently detected in the maternal genitalia, followed by M. hominis. Women who were in labor for a longer period of time had a higher risk of vertically transmitting STI agents to their neonates.</p><p><strong>Conclusions: </strong>Vertical transmission of bacterial STIs from mothers to their infants is possible at delivery and influenced by the duration of labor. STIs should be diagnosed in pregnant women to prevent vertical transmission from the mother to the infant at the time of delivery.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2014.880183","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32138580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Bacterial meningitis in adults in Iceland, 1995-2010. 1995-2010年冰岛成人细菌性脑膜炎
Pub Date : 2014-05-01 Epub Date: 2014-02-25 DOI: 10.3109/00365548.2014.880184
Asgerður Thornórðardóttir, Helga Erlendsdóttir, Bryndís Sigurðardóttir, Hjördís Harðardóttir, Ingi Karl Reynisson, Magnús Gottfreðsson, Sigurður Guðmundsson

Introduction: Bacterial meningitis is a serious disease with a mortality rate of 15-20% in adults. We conducted a population-based study of bacterial meningitis in adults (≥ 16 y) in Iceland, 1995-2010.

Methods: Cases were identified based on positive bacterial cultures from cerebrospinal fluid (CSF) and/or the ICD codes for bacterial meningitis. Medical charts were reviewed and outcomes were assessed using the national population registry. The study period was divided into 2 equal parts, 1995-2002 and 2003-2010, before and after implementation of routine childhood vaccination against serogroup C meningococci, respectively.

Results: In total, 111 episodes occurred in 110 individuals. The most common causative organisms were Neisseria meningitidis (41%) and Streptococcus pneumoniae (30%). Only 30% of the patients presented with the classical symptom triad of fever, neck stiffness, and an altered mental status. The overall incidence was 3.2/100,000 inhabitants/y, and dropped significantly between the first and second halves of the study (p = 0.03). This drop was due to a reduced incidence of N. meningitidis meningitis: 34 and 12 cases in the first and second periods, respectively (p = 0.006). The incidence of meningitis caused by S. pneumoniae remained unchanged. The case fatality rates were 18% and 13% in the first and second halves of the study, respectively (difference not significant).

Conclusions: The incidence of bacterial meningitis has decreased since the implementation of meningococcal C vaccination in 2002. However, the case fatality rate has remained unchanged.

细菌性脑膜炎是一种严重的疾病,成人死亡率为15-20%。1995-2010年,我们在冰岛进行了一项以人群为基础的成人(≥16岁)细菌性脑膜炎研究。方法:根据脑脊液(CSF)细菌培养阳性和/或细菌性脑膜炎的ICD代码来确定病例。使用国家人口登记处审查了医疗图表并评估了结果。研究期间分为1995-2002年和2003-2010年两部分,分别在实施常规儿童C群脑膜炎球菌疫苗接种之前和之后。结果:110例患者共发生111次发作。最常见的病原菌是脑膜炎奈瑟菌(41%)和肺炎链球菌(30%)。只有30%的患者表现出发烧、颈部僵硬和精神状态改变的经典症状。总体发病率为3.2/100,000居民/年,在研究的前、后半段之间显著下降(p = 0.03)。这一下降是由于脑膜炎奈瑟菌脑膜炎发病率降低:第一和第二阶段分别为34例和12例(p = 0.006)。肺炎链球菌引起的脑膜炎发病率保持不变。在研究的前半部分和后半部分,病死率分别为18%和13%(差异不显著)。结论:自2002年实施C型脑膜炎球菌疫苗接种以来,细菌性脑膜炎的发病率有所下降。然而,病死率保持不变。
{"title":"Bacterial meningitis in adults in Iceland, 1995-2010.","authors":"Asgerður Thornórðardóttir,&nbsp;Helga Erlendsdóttir,&nbsp;Bryndís Sigurðardóttir,&nbsp;Hjördís Harðardóttir,&nbsp;Ingi Karl Reynisson,&nbsp;Magnús Gottfreðsson,&nbsp;Sigurður Guðmundsson","doi":"10.3109/00365548.2014.880184","DOIUrl":"https://doi.org/10.3109/00365548.2014.880184","url":null,"abstract":"<p><strong>Introduction: </strong>Bacterial meningitis is a serious disease with a mortality rate of 15-20% in adults. We conducted a population-based study of bacterial meningitis in adults (≥ 16 y) in Iceland, 1995-2010.</p><p><strong>Methods: </strong>Cases were identified based on positive bacterial cultures from cerebrospinal fluid (CSF) and/or the ICD codes for bacterial meningitis. Medical charts were reviewed and outcomes were assessed using the national population registry. The study period was divided into 2 equal parts, 1995-2002 and 2003-2010, before and after implementation of routine childhood vaccination against serogroup C meningococci, respectively.</p><p><strong>Results: </strong>In total, 111 episodes occurred in 110 individuals. The most common causative organisms were Neisseria meningitidis (41%) and Streptococcus pneumoniae (30%). Only 30% of the patients presented with the classical symptom triad of fever, neck stiffness, and an altered mental status. The overall incidence was 3.2/100,000 inhabitants/y, and dropped significantly between the first and second halves of the study (p = 0.03). This drop was due to a reduced incidence of N. meningitidis meningitis: 34 and 12 cases in the first and second periods, respectively (p = 0.006). The incidence of meningitis caused by S. pneumoniae remained unchanged. The case fatality rates were 18% and 13% in the first and second halves of the study, respectively (difference not significant).</p><p><strong>Conclusions: </strong>The incidence of bacterial meningitis has decreased since the implementation of meningococcal C vaccination in 2002. However, the case fatality rate has remained unchanged.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2014.880184","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32152442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Use of interferon gamma release assays in clinical practice: review of QuantiFERON-TB prescription in a French university hospital. 干扰素γ释放法在临床实践中的应用:对法国某大学医院QuantiFERON-TB处方的回顾。
Pub Date : 2014-05-01 Epub Date: 2014-03-19 DOI: 10.3109/00365548.2014.887221
Magali Briere, Albert Sotto, Marie Audrain, David Boutoille, Virginie Nael, Claire Bernier, Frederique Naudin, Pascale Bemer

Background: In recent years, the clinical use of interferon gamma release assays (IGRAs) has increased exponentially, while their indications remain controversial given difficulties in interpretation. Four indications were recommended by the French National Authority for Health (HAS) in 2006. We evaluated the utilization of the QuantiFERON-TB Gold In-Tube (QFT-IT) test over a 1-y period in a French university hospital and the impact of IGRA results in particular.

Methods: The QFT-IT tests requested in 2009 were analysed retrospectively, excluding those from the Occupational Health Department, the Regional Tuberculosis Centre, and rheumatology consultations for which the indications were clearly defined.

Results: Three hundred and sixty QFT-IT tests were analysed. The interpretation was frequently problematic given the inclusion of a significant proportion of patients over 80 y of age (11%), immunocompromised patients (43%), and patients with a known history of tuberculosis (6%). The indications failed to comply with HAS recommendations in 42% of cases (151/360), i.e. 14% of all QFT-IT tests in 2009. Thirty-seven percent of request forms were related to suspected pulmonary tuberculosis. In the case of a positive QFT-IT test, the clinical decision-making was changed in 58% of cases when the indications met the HAS recommendations, compared with only 16% if they did not (p < 0.005).

Conclusion: When the indications do not meet the health authority recommendations, the diagnostic value of the IGRA remains limited.

背景:近年来,临床使用干扰素γ释放法(IGRAs)呈指数增长,但由于解释困难,其适应症仍然存在争议。2006年,法国国家卫生管理局(HAS)推荐了四种适应症。我们评估了QuantiFERON-TB管内金(QFT-IT)测试在法国大学医院1年期间的使用情况,特别是IGRA结果的影响。方法:回顾性分析2009年要求的QFT-IT测试,不包括来自职业卫生部门、地区结核病中心和风湿病学咨询的适应症明确定义的测试。结果:对360例QFT-IT试验进行了分析。由于纳入了相当大比例的80岁以上患者(11%)、免疫功能低下患者(43%)和已知结核病史患者(6%),这种解释经常存在问题。42%的病例(151/360)的适应症不符合HAS的建议,即占2009年所有QFT-IT测试的14%。37%的申请表与疑似肺结核有关。在QFT-IT测试阳性的情况下,当适应症符合HAS建议时,58%的病例会改变临床决策,而如果不符合HAS建议,只有16%的病例会改变临床决策(p < 0.005)。结论:当适应症不符合卫生主管部门的建议时,IGRA的诊断价值仍然有限。
{"title":"Use of interferon gamma release assays in clinical practice: review of QuantiFERON-TB prescription in a French university hospital.","authors":"Magali Briere,&nbsp;Albert Sotto,&nbsp;Marie Audrain,&nbsp;David Boutoille,&nbsp;Virginie Nael,&nbsp;Claire Bernier,&nbsp;Frederique Naudin,&nbsp;Pascale Bemer","doi":"10.3109/00365548.2014.887221","DOIUrl":"https://doi.org/10.3109/00365548.2014.887221","url":null,"abstract":"<p><strong>Background: </strong>In recent years, the clinical use of interferon gamma release assays (IGRAs) has increased exponentially, while their indications remain controversial given difficulties in interpretation. Four indications were recommended by the French National Authority for Health (HAS) in 2006. We evaluated the utilization of the QuantiFERON-TB Gold In-Tube (QFT-IT) test over a 1-y period in a French university hospital and the impact of IGRA results in particular.</p><p><strong>Methods: </strong>The QFT-IT tests requested in 2009 were analysed retrospectively, excluding those from the Occupational Health Department, the Regional Tuberculosis Centre, and rheumatology consultations for which the indications were clearly defined.</p><p><strong>Results: </strong>Three hundred and sixty QFT-IT tests were analysed. The interpretation was frequently problematic given the inclusion of a significant proportion of patients over 80 y of age (11%), immunocompromised patients (43%), and patients with a known history of tuberculosis (6%). The indications failed to comply with HAS recommendations in 42% of cases (151/360), i.e. 14% of all QFT-IT tests in 2009. Thirty-seven percent of request forms were related to suspected pulmonary tuberculosis. In the case of a positive QFT-IT test, the clinical decision-making was changed in 58% of cases when the indications met the HAS recommendations, compared with only 16% if they did not (p < 0.005).</p><p><strong>Conclusion: </strong>When the indications do not meet the health authority recommendations, the diagnostic value of the IGRA remains limited.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2014.887221","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32247841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Outbreaks of methicillin-resistant Staphylococcus aureus among staff and dogs in Swedish small animal hospitals. 瑞典小动物医院工作人员和狗中爆发耐甲氧西林金黄色葡萄球菌。
Pub Date : 2014-04-01 Epub Date: 2014-01-23 DOI: 10.3109/00365548.2013.866267
Ulrika Grönlund Andersson, Anders Wallensten, Sara Hæggman, Christina Greko, Göran Hedin, Ingegerd Hökeberg, Fredrik Lindström, Barbro Olsson-Liljequist, Jan Smedjegård, Tomas Söderblom, Ulrika Windahl, Johan Struwe

Methicillin-resistant Staphylococcus aureus (MRSA) was found in a dog for the first time in Sweden in 2006. Between October 2006 and May 2007, MRSA was diagnosed in 7 more dogs that had been treated in 3 different small animal hospitals, located 150-200 km apart, in different counties of Sweden. Screening of the animal hospital staff and environment in these small animal hospitals showed 20 of 152 staff to be positive for MRSA, with rates between 2% and 18% in the different hospitals, while all 128 environmental samples were negative. All MRSA isolates from dogs and staff belonged to spa type t032, were Panton-Valentine leukocidin (PVL)-negative, and had indistinguishable pulsed-field gel electrophoresis patterns, except for 2 isolates with closely related patterns. To our knowledge, this is the first report of multiple outbreaks of MRSA in dogs caused by the same strain within a short time frame, and appearing in a country with low prevalence of MRSA in both humans and dogs. This highlights the importance of infection control programs in animal hospitals and in animal health care. Awareness of MRSA as an occupational risk for veterinary personnel is essential.

2006年,瑞典首次在狗身上发现了耐甲氧西林金黄色葡萄球菌(MRSA)。2006年10月至2007年5月期间,在瑞典不同县相距150-200公里的3家不同的小型动物医院接受治疗的另外7只狗被诊断出耐甲氧西林金黄色葡萄球菌。对这些小型动物医院的动物医院工作人员和环境的筛查显示,152名工作人员中有20人对MRSA呈阳性,不同医院的比例在2%至18%之间,而所有128个环境样本均为阴性。犬和工作人员MRSA分离株均为spa型t032, pton - valentine leukocidin (PVL)阴性,除2株具有密切相关的脉冲场凝胶电泳图谱外,其余均无明显差异。据我们所知,这是第一次在短时间内由同一菌株引起的犬类MRSA多次暴发的报告,并且出现在一个人与犬类MRSA流行率均较低的国家。这突出了动物医院和动物保健感染控制项目的重要性。对兽医人员来说,认识到MRSA是一种职业风险是必要的。
{"title":"Outbreaks of methicillin-resistant Staphylococcus aureus among staff and dogs in Swedish small animal hospitals.","authors":"Ulrika Grönlund Andersson,&nbsp;Anders Wallensten,&nbsp;Sara Hæggman,&nbsp;Christina Greko,&nbsp;Göran Hedin,&nbsp;Ingegerd Hökeberg,&nbsp;Fredrik Lindström,&nbsp;Barbro Olsson-Liljequist,&nbsp;Jan Smedjegård,&nbsp;Tomas Söderblom,&nbsp;Ulrika Windahl,&nbsp;Johan Struwe","doi":"10.3109/00365548.2013.866267","DOIUrl":"https://doi.org/10.3109/00365548.2013.866267","url":null,"abstract":"<p><p>Methicillin-resistant Staphylococcus aureus (MRSA) was found in a dog for the first time in Sweden in 2006. Between October 2006 and May 2007, MRSA was diagnosed in 7 more dogs that had been treated in 3 different small animal hospitals, located 150-200 km apart, in different counties of Sweden. Screening of the animal hospital staff and environment in these small animal hospitals showed 20 of 152 staff to be positive for MRSA, with rates between 2% and 18% in the different hospitals, while all 128 environmental samples were negative. All MRSA isolates from dogs and staff belonged to spa type t032, were Panton-Valentine leukocidin (PVL)-negative, and had indistinguishable pulsed-field gel electrophoresis patterns, except for 2 isolates with closely related patterns. To our knowledge, this is the first report of multiple outbreaks of MRSA in dogs caused by the same strain within a short time frame, and appearing in a country with low prevalence of MRSA in both humans and dogs. This highlights the importance of infection control programs in animal hospitals and in animal health care. Awareness of MRSA as an occupational risk for veterinary personnel is essential.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2013.866267","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32051368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
期刊
Scandinavian Journal of Infectious Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1